These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15123617)

  • 1. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
    Massa A; Barbieri F; Aiello C; Arena S; Pattarozzi A; Pirani P; Corsaro A; Iuliano R; Fusco A; Zona G; Spaziante R; Florio T; Schettini G
    J Biol Chem; 2004 Jul; 279(28):29004-12. PubMed ID: 15123617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
    Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
    Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
    Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F; Iuliano R; Boccia A; Stella A; Visconti R; Bruni P; Baldassarre G; Santoro M; Viglietto G; Fusco A
    Mol Cell Biol; 2000 Dec; 20(24):9236-46. PubMed ID: 11094075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
    Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Pera IL; Iuliano R; Florio T; Susini C; Trapasso F; Santoro M; Chiariotti L; Schettini G; Viglietto G; Fusco A
    Oncogene; 2005 Apr; 24(19):3187-95. PubMed ID: 15735685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells.
    Held-Feindt J; Forstreuter F; Pufe T; Mentlein R
    Brain Res Mol Brain Res; 2001 Feb; 87(1):12-21. PubMed ID: 11223155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
    Florio T
    Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
    Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
    Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T; Scorziello A; Thellung S; Salzano S; Berlingieri MT; Fusco A; Schettini G
    Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A
    Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus.
    Hernández-Pinto AM; Puebla-Jiménez L; Perianes-Cachero A; Arilla-Ferreiro E
    J Nutr Biochem; 2013 May; 24(5):848-58. PubMed ID: 22902329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene.
    Florio T; Scorizello A; Fattore M; D'Alto V; Salzano S; Rossi G; Berlingieri MT; Fusco A; Schettini G
    J Biol Chem; 1996 Mar; 271(11):6129-36. PubMed ID: 8626400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
    Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.